TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|8|1959-1963

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.8, 2015-08, pp. : 1959-1963

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients

By  

HEPATOLOGY, Vol. 62, Iss. 1, 2015-07 ,pp. : 111-117

John Wiley & Sons Inc

Access to resources Recommend Favorite

PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in nonalcoholic fatty liver disease

By  

HEPATOLOGY, Vol. 62, Iss. 2, 2015-08 ,pp. : 658-659

John Wiley & Sons Inc

Access to resources Recommend Favorite

PNPLA3 as a liver steatosis risk factor following living‐donor liver transplantation for hepatitis C

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E335-E339

John Wiley & Sons Inc

Access to resources Recommend Favorite

The common I148 M variant of PNPLA3 does not predict fibrosis progression after liver transplantation for hepatitis C

By  

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1483-1484

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of IL28B and PNPLA3 polymorphisms on treatment outcomes in patients infected with genotype 6 hepatitis C virus

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 6, 2015-06 ,pp. : 1040-1048

John Wiley & Sons Inc

Access to resources Recommend Favorite